Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism had higher plasma PAI-1 concentrations and higher risk of death than those with the 4G/5G or 5G/5G genotypes; one study involved 175 children with meningococcal disease, and the other included 88 adult patients with septic shock. 26066833 2015
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group LHGDN Our data show a correlation between the 4G4G genotype of the PAI-1 gene and development of DIC in meningococcal infection. 17697137 2007
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE Our data show a correlation between the 4G4G genotype of the PAI-1 gene and development of DIC in meningococcal infection. 17697137 2007
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE Our data show a correlation between the 4G/4G genotype in the plasminogen activator inhibitor-1 gene and poor outcome in children with meningococcal infection. 15843979 2005
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group LHGDN The 4G/5G insertion/deletion promoter polymorphism, which leads to differences in PAI-1 production, has been demonstrated to affect the risk of developing severe complications and dying from sepsis during meningococcal infection and multiple trauma. 16237647 2005
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE The 4G/5G insertion/deletion promoter polymorphism, which leads to differences in PAI-1 production, has been demonstrated to affect the risk of developing severe complications and dying from sepsis during meningococcal infection and multiple trauma. 16237647 2005
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE Hence, the deletion polymorphism (4G) within the promoter region of the plasminogen activator inhibitor-1 gene leads to impaired fibrinolysis and influences the severity and outcome of meningococcal disease and the susceptibility to severe sepsis and multiple organ failure after trauma. 15118537 2004
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 Biomarker group BEFREE To assess the relevance of genetically determined host factors for the prognosis of meningococcal disease, Fc gamma receptor IIA (FcgammaRIIA), the tumor necrosis factor alpha (TNF-alpha) gene promoter region, and plasminogen-activator-inhibitor-1 (PAI-1) gene polymorphisms were studied in 145 patients with meningococcal disease and in 290 healthy controls matched by sex. 15243816 2004
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE This study confirms that Caucasian pediatric patients carrying the functional PAI-1 4G/4G genotype are at an increased risk of developing vascular complications and dying from meningococcal disease. 14668616 2003
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE Because we had no information on genotypes of patients who died, we also genotyped 183 first-degree relatives of a consecutive series of patients with meningococcal infection for the 4G/5G deletion/insertion polymorphism in the promoter region of the plasminogen-activator-inhibitor-1 gene (PAI-1). 10470701 1999
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.090 GeneticVariation group BEFREE The relation between meningococcal disease outcome, PAI-1 concentration, and PAI-1 genotype was investigated in 175 children with meningococcal disease (37 from Rotterdam, the Netherlands, and 138 from London, UK) and 226 controls (137 from Rotterdam, 89 from London). 10470700 1999